Suppr超能文献

多胺在癫痫及癫痫相关病理生理改变中的潜在作用

The Potential Role of Polyamines in Epilepsy and Epilepsy-Related Pathophysiological Changes.

机构信息

Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, NO. 1 Xinmin Street, Changchun 130021, China.

出版信息

Biomolecules. 2022 Oct 29;12(11):1596. doi: 10.3390/biom12111596.

Abstract

Epilepsy is one of the most common neurological disorders and severely impacts the life quality of patients. Polyamines are ubiquitous, positively charged aliphatic amines that are present at a relatively high level and help regulate the maintenance of cell membrane excitability and neuronal physiological functions in the central nervous system. Studies have shown abnormalities in the synthesis and catabolism of polyamines in patients with epilepsy and in animal models of epilepsy. The polyamine system seems to involve in the pathophysiological processes of epilepsy via several mechanisms such as the regulation of ion permeability via interaction with ion channels, involvement in antioxidation as hydroperoxide scavengers, and the induction of cell damage via the production of toxic metabolites. In this review, we try to describe the possible associations between polyamines and epilepsy and speculate that the polyamine system is a potential target for the development of novel strategies for epilepsy treatment.

摘要

癫痫是最常见的神经障碍之一,严重影响患者的生活质量。多胺是普遍存在的、带正电荷的脂肪族胺,在中枢神经系统中以相对较高的水平存在,有助于调节细胞膜兴奋性和神经元生理功能的维持。研究表明,癫痫患者和癫痫动物模型中多胺的合成和分解代谢存在异常。多胺系统似乎通过几种机制参与癫痫的病理生理过程,例如通过与离子通道相互作用调节离子通透性、作为过氧化物清除剂参与抗氧化作用以及通过产生有毒代谢物诱导细胞损伤。在这篇综述中,我们试图描述多胺与癫痫之间可能的关联,并推测多胺系统是开发新型癫痫治疗策略的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4696/9687137/89aea15d11d8/biomolecules-12-01596-g001.jpg

相似文献

4
[Polyamines and mental diseases].[多胺与精神疾病]
Vestn Ross Akad Med Nauk. 2006(2):45-51.
5
Toxicity of polyamines and their metabolic products.多胺及其代谢产物的毒性
Chem Res Toxicol. 2013 Dec 16;26(12):1782-800. doi: 10.1021/tx400316s. Epub 2013 Nov 25.
6
The old and new biochemistry of polyamines.多胺的新旧生物化学。
Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):2053-2068. doi: 10.1016/j.bbagen.2018.06.004. Epub 2018 Jun 8.
8
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.神经疾病中的谷氨酸受体抗体:抗AMPA - GluR3抗体、抗NMDA - NR1抗体、抗NMDA - NR2A/B抗体、抗mGluR1抗体或抗mGluR5抗体存在于以下疾病患者的亚组中:癫痫、脑炎、小脑共济失调、系统性红斑狼疮(SLE)和神经精神性SLE、干燥综合征、精神分裂症、躁狂症或中风。这些自身免疫性抗谷氨酸受体抗体可在少数脑区与神经元结合,激活谷氨酸受体,降低谷氨酸受体的表达,损害谷氨酸诱导的信号传导和功能,激活血脑屏障内皮细胞,杀死神经元,损伤大脑,在动物模型中诱发行为/精神/认知异常和共济失调,并且在一些患者中可通过免疫疗法去除或使其失活。
J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1.

本文引用的文献

8
Kainate receptors and synaptic plasticity.红藻氨酸受体与突触可塑性。
Neuropharmacology. 2021 Sep 15;196:108540. doi: 10.1016/j.neuropharm.2021.108540. Epub 2021 Mar 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验